O
OrbiMed Portfolio holdings
AUM
$3.98B
This Quarter Return
-1.08%
1 Year Return
+13.05%
3 Year Return
+159.74%
5 Year Return
+207.27%
10 Year Return
+1,027.33%
AUM
$7.88B
AUM Growth
+$7.88B
(-24%)
Cap. Flow
-$1.99B
Cap. Flow
% of AUM
-25.25%
Top 10 Holdings %
Top 10 Hldgs %
34.76%
Holding
148
New
11
Increased
16
Reduced
57
Closed
17
Top Buys
| 1 |
Regeneron Pharmaceuticals
REGN
|
$106M |
| 2 |
Amicus Therapeutics
FOLD
|
$80.2M |
| 3 |
LOXO
Loxo Oncology, Inc
LOXO
|
$77.8M |
| 4 |
Rhythm Pharmaceuticals
RYTM
|
$43.5M |
| 5 |
scPharmaceuticals
SCPH
|
$41.2M |
Top Sells
| 1 |
Incyte
INCY
|
$172M |
| 2 |
AET
Aetna Inc
AET
|
$171M |
| 3 |
Biogen
BIIB
|
$127M |
| 4 |
Merck
MRK
|
$105M |
| 5 |
Gilead Sciences
GILD
|
$101M |
Sector Composition
| 1 | Healthcare | 91.38% |
| 2 | Financials | 1.43% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
VRAY
26
DELISTED
ViewRay, Inc.
VRAY
| $87.6M | 1.11% | 9,458,567 | – | – |
|
|
GBT
27
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $84.9M | 1.07% | 2,157,730 -235,905 | -10% | -$9.28M |
|
|
JUNO
28
DELISTED
Juno Therapeutics, Inc.
JUNO
| $83.9M | 1.06% | 1,835,188 -206,420 | -10% | -$9.44M |
|
|
MGLN
29
DELISTED
Magellan Health Services, Inc.
MGLN
| $82.6M | 1.05% | 855,843 -26,757 | -3% | -$2.58M |
|
30
Jazz Pharmaceuticals
JAZZ
$7.75B
| $81.9M | 1.04% | 607,900 -141,300 | -19% | -$19M |
|
|
AET
31
DELISTED
Aetna Inc
AET
| $80.7M | 1.02% | 447,552 -948,948 | -68% | -$171M |
|
|
32
Amicus Therapeutics
FOLD
$2.34B
| $80.2M | 1.01% | +5,572,500 | New | +$80.2M |
|
|
AERI
33
DELISTED
Aerie Pharmaceuticals, Inc.
AERI
| $79.4M | 1% | 1,329,600 -108,582 | -8% | -$6.49M |
|
|
LOXO
34
DELISTED
Loxo Oncology, Inc
LOXO
| $79.2M | 1% | 94,100,036 +92,372,036 | +5,346% | +$77.8M |
|
35
Viatris
VTRS
$12.3B
| $77.6M | 0.98% | 1,834,300 -1,766,800 | -49% | -$74.8M |
|
36
Thermo Fisher Scientific
TMO
$186B
| $73.9M | 0.94% | 389,400 -144,800 | -27% | -$27.5M |
|
37
Illumina
ILMN
$15.8B
| $71.8M | 0.91% | 328,500 -70,000 | -18% | -$15.3M |
|
|
BLUE
38
DELISTED
bluebird bio
BLUE
| $68.4M | 0.87% | 384,046 -97,900 | -20% | -$17.4M |
|
39
Ironwood Pharmaceuticals
IRWD
$214M
| $67.8M | 0.86% | 4,525,200 -1,234,000 | -21% | -$18.5M |
|
40
Johnson & Johnson
JNJ
$427B
| $65M | 0.82% | 465,300 -659,100 | -59% | -$92.1M |
|
|
NVRO
41
DELISTED
NEVRO CORP.
NVRO
| $62M | 0.78% | 897,791 +402,891 | +81% | +$27.8M |
|
42
Intuitive Surgical
ISRG
$170B
| $56.1M | 0.71% | 153,600 +97,200 | +172% | +$35.5M |
|
43
Corvus Pharmaceuticals
CRVS
$428M
| $55.7M | 0.7% | 5,379,349 | – | – |
|
|
PVLA
44
Palvella Therapeutics, Inc. Common Stock
PVLA
$599M
| $54.8M | 0.69% | 7,259,620 | – | – |
|
45
Assembly Biosciences
ASMB
$190M
| $54.2M | 0.69% | 1,198,026 +450,000 | +60% | +$20.4M |
|
46
UnitedHealth
UNH
$281B
| $52.8M | 0.67% | 239,500 -140,500 | -37% | -$31M |
|
|
INSY
47
DELISTED
Insys Therapeutics, Inc.
INSY
| $52M | 0.66% | 5,406,844 -764,596 | -12% | -$7.36M |
|
|
AGN
48
DELISTED
Allergan plc
AGN
| $47M | 0.59% | 287,290 -86,300 | -23% | -$14.1M |
|
49
Insmed
INSM
$28.8B
| $46.7M | 0.59% | 1,496,791 -378,225 | -20% | -$11.8M |
|
50
Galapagos
GLPG
$2.07B
| $45.7M | 0.58% | 486,990 -36,800 | -7% | -$3.45M |
|